The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Adalimumab
Australian Public Assessment Report
Device/Product Name
Idacio
Active ingredients
Adalimumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-03192-1-1
Submission Type
New biosimilar medicine
Decision
Approved